VCEL logo

Vericel Corporation (VCEL)

Profile

Full Name

Vericel Corporation

Ticker

NASDAQ: VCEL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 4, 1997

Indexes

Not included

Website

https://www.vcel.com

Employees

357

Key Details

Price

$38.75(4.17%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$237.22M(20.10% YoY)

Annual EPS

$0.20(399.70% YoY)

PE Ratio

311.00

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $38.75
    VCEL price is $38.75

    30-Day Relative Volume

    2.78
    VCEL 30-day relative volume is 2.78

    Price Performance

    Price 1-Day Change

    +4.17%
    VCEL price is up +4.17% today

    Price YTD Change

    -29.43%
    VCEL price is down -29.43% since January 1st

    Price 1-Year Change

    -19.34%
    VCEL price is down -19.34% year-on-year

    Price 3-Year Change

    +55.25%
    VCEL price is up +55.25% over the past 3 years

    Price Range

    Price All-Time High

    $1590.00
    VCEL price is currently -97.56% below its historical high of $1590.00

    Price 3-Year Low

    $17.30
    VCEL price is currently +123.99% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $1.96B
    VCEL market cap is $1.96 billion

    Market Cap 3-Year Change

    +65.89%
    VCEL market cap is up +65.89% over the past 3 years

    Market Cap All-Time High

    $3.14B
    VCEL market cap is currently -37.80% below its historical high of $3.14 billion

    Market Cap Sector Percentile

    80.47%
    VCEL market cap is higher than 80.47% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.23%
    VCEL shares outstanding is up +2.23% year-on-year

    Shares Outstanding 3-Year Change

    +6.86%
    VCEL shares outstanding is up +6.86% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.18
    VCEL beta is 1.18

    200-day SMA

    $41.55
    VCEL price is currently -6.73% below its 200-day simple moving average

    50-day SMA

    $33.66
    VCEL price is currently +15.12% above its 50-day simple moving average

    14-Day RSI

    60.47
    VCEL 14-day relative strength index is 60.47

    Volume

    2.78
    VCEL 30-day relative volume is 2.78

    ATR

    $1.59
    VCEL average true range is $1.59

    10-day Historical Volatility

    42.60%
    VCEL 10-day historical volatility is 42.60%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $237.22M
    VCEL annual revenue is $237.22 million

    Revenue Analysts Estimate

    $275.21M
    VCEL annual revenue is currently -13.80% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +20.1%
    VCEL annual revenue is up +20.1% year-on-year

    Revenue Sector Percentile

    75.76%
    VCEL annual revenue is higher than 75.76% of companies in Healthcare sector

    EPS

    EPS

    $0.20
    VCEL annual earnings per share is $0.20

    EPS Analysts Estimate

    $0.18
    VCEL annual earnings per share is currently +11.39% higher than the consensus analysts' forecast

    EPS 1-Year Change

    +399.7%
    VCEL annual earnings per share is up +399.7% year-on-year

    EPS Sector Percentile

    84.43%
    VCEL annual earnings per share is higher than 84.43% of companies in Healthcare sector

    Profit

    Gross Profit

    $172.11M
    VCEL annual gross profit is $172.11 million

    Gross Margin

    72.55%
    VCEL annual gross profit margin is 72.55%

    Operating Profit

    $4.52M
    VCEL annual operating income is $4.52 million

    Operating Margin

    1.91%
    VCEL annual operating profit margin is 1.91%

    Net Income

    $10.36M
    VCEL annual net profit is $10.36 million

    Net Margin

    4.37%
    VCEL annual net profit margin is 4.37%

    Expenses

    Total Expenses

    $232.71M
    VCEL annual total expenses is $232.71 million

    Operating Expenses

    $167.59M
    VCEL annual total operating expenses is $167.59 million

    Cost Of Goods Sold

    $65.12M
    VCEL annual cost of goods sold is $65.12 million

    Selling, General & Administrative Expenses

    $142.79M
    VCEL annual SG&A is $142.79 million

    Depreciation & Amortization

    $5.50M
    VCEL annual D&A is $5.50 million

    Interest Expense

    $0.00
    VCEL annual interest expense is $0.00

    Income Tax

    $148.00K
    VCEL annual income tax is $148.00 thousand

    EBIT & EBITDA

    EBIT

    $11.12M
    VCEL annual earnings before interest & taxes is $11.12 million

    EBITDA

    $16.63M
    VCEL annual EBITDA is $16.63 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $432.72M
    VCEL annual total assets is $432.72 million

    Non Current Assets

    $219.94M
    VCEL annual long term assets is $219.94 million

    Current Assets

    $212.78M
    VCEL annual total current assets is $212.78 million

    Cash and Cash Equivalents

    $74.52M
    VCEL annual cash & cash equivalents is $74.52 million

    Accounts Receivable

    $61.38M
    VCEL annual accounts receivable is $61.38 million

    Inventory

    $17.37M
    VCEL annual inventory is $17.37 million

    Liabilities

    Total Liabilities

    $140.75M
    VCEL annual total liabilities is $140.75 million

    Long Term Liabilities

    $90.47M
    VCEL annual total long term liabilities is $90.47 million

    Current Liabilities

    $50.29M
    VCEL annual current liabilities is $50.29 million

    Accounts Payable

    $23.85M
    VCEL annual accounts payable is $23.85 million

    Debt

    Total Debt

    $99.84M
    VCEL annual total debt is $99.84 million

    Total Debt 1-Year Change

    +13.27%
    VCEL annual total debt is up +13.27% year-on-year

    Long Term Debt

    $90.47M
    VCEL annual long term debt is $90.47 million

    Short Term Debt

    $9.37M
    VCEL annual short term debt is $9.37 million

    Equity & Capital

    Shareholders Equity

    $291.97M
    VCEL annual stockholders equity is $291.97 million

    Book Value

    $291.97M
    VCEL annual book value is $291.97 million

    Retained Earnings

    -$392.81M
    VCEL annual retained earnings is -$392.81 million

    Working Capital

    $162.49M
    VCEL annual working capital is $162.49 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    $58.16M
    VCEL annual cash from operations is $58.16 million

    Cash From Operations 1-Year Change

    +64.72%
    VCEL annual cash from operations is up +64.72% year-on-year

    Cash From Investing

    -$79.03M
    VCEL annual cash from investing is -$79.03 million

    Cash From Investing 1-Year Change

    -2425.05%
    VCEL annual cash from investing is down -2425.05% year-on-year

    Cash From Financing

    $19.05M
    VCEL annual cash from financing is $19.05 million

    Cash From Financing 1-Year Change

    +426.64%
    VCEL annual cash from financing is up +426.64% year-on-year

    CAPEX

    CAPEX

    $63.97M
    VCEL annual capital expenditures is $63.97 million

    CAPEX 1-Year Change

    +132.52%
    VCEL annual capital expenditures is up +132.52% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$5.81M
    VCEL annual free cash flow is -$5.81 million

    Free Cash Flow 1-Year Change

    -174.52%
    VCEL annual free cash flow is down -174.52% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    72.55%
    VCEL annual gross profit margin is 72.55%

    Operating Margin

    1.91%
    VCEL annual operating profit margin is 1.91%

    Net Margin

    4.37%
    VCEL annual net profit margin is 4.37%

    ROA & ROE

    ROA

    2.64%
    VCEL annual return on assets is 2.64%

    ROE

    4.00%
    VCEL annual return on equity is 4.00%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    311.00
    VCEL price to earnings ratio is 311.00

    PE Ratio Sector Percentile

    96.71%
    VCEL price to earnings ratio is higher than 96.71% of companies in Healthcare sector

    PB Ratio

    PB Ratio

    6.37
    VCEL price to book ratio is 6.37

    PB Ratio Sector Percentile

    82.01%
    VCEL price to book ratio is higher than 82.01% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    7.85
    VCEL price to sales ratio is 7.85

    PS Ratio Sector Percentile

    67.49%
    VCEL price to sales ratio is higher than 67.49% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $1.98B
    VCEL enterprise value is $1.98 billion

    Enterprise Value Sector Percentile

    80.08%
    VCEL enterprise value is higher than 80.08% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    122.09
    VCEL EV/EBITDA is 122.09

    EV/EBITDA Sector Percentile

    98.55%
    VCEL EV/EBITDA is higher than 98.55% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    4.23
    VCEL annual current ratio is 4.23

    Quick Ratio

    3.89
    VCEL annual quick ratio is 3.89

    Leverage

    Debt To Equity

    0.00
    VCEL annual debt to equity ratio is 0.00

    Interest Coverage Ratio

    -
    VCEL annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    7
    VCEL piotroski f-score is 7

    Altman Z-Score

    8.15
    VCEL altman z-score is 8.15

    Analyst ratings

    Recent major analysts updates

    Oct 15, 25 Truist Securities
    Buy
    Sep 17, 25 BTIG
    Neutral
    Aug 1, 25 Canaccord Genuity
    Buy
    Jun 16, 25 Stephens & Co.
    Overweight
    May 22, 25 Stephens & Co.
    Overweight
    Apr 11, 25 Truist Securities
    Buy
    Mar 3, 25 Truist Securities
    Buy
    Feb 28, 25 HC Wainwright & Co.
    Buy
    Feb 3, 25 Canaccord Genuity
    Buy
    Jan 15, 25 Stephens & Co.
    Overweight

    Institutional Ownership

    Screeners with VCEL included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    Earnings today
    NASDAQ Dividend Calendar
    • What is the ticker symbol for Vericel Corporation?
    • Does Vericel Corporation pay dividends?
    • What sector is Vericel Corporation in?
    • What industry is Vericel Corporation in?
    • What country is Vericel Corporation based in?
    • When did Vericel Corporation go public?
    • Is Vericel Corporation in the S&P 500?
    • Is Vericel Corporation in the NASDAQ 100?
    • Is Vericel Corporation in the Dow Jones?
    • When was Vericel Corporation's last earnings report?
    • When does Vericel Corporation report earnings?

    What is the ticker symbol for Vericel Corporation?

    The ticker symbol for Vericel Corporation is NASDAQ:VCEL

    Does Vericel Corporation pay dividends?

    No, Vericel Corporation does not pay dividends

    What sector is Vericel Corporation in?

    Vericel Corporation is in the Healthcare sector

    What industry is Vericel Corporation in?

    Vericel Corporation is in the Biotechnology industry

    What country is Vericel Corporation based in?

    Vericel Corporation is headquartered in United States

    When did Vericel Corporation go public?

    Vericel Corporation's initial public offering (IPO) was on February 4, 1997

    Is Vericel Corporation in the S&P 500?

    No, Vericel Corporation is not included in the S&P 500 index

    Is Vericel Corporation in the NASDAQ 100?

    No, Vericel Corporation is not included in the NASDAQ 100 index

    Is Vericel Corporation in the Dow Jones?

    No, Vericel Corporation is not included in the Dow Jones index

    When was Vericel Corporation's last earnings report?

    Vericel Corporation's most recent earnings report was on July 31, 2025

    When does Vericel Corporation report earnings?

    The next expected earnings date for Vericel Corporation is November 6, 2025
    On this page